Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Neuroene Therapeutics logo — Developing mitochondrial small molecule drugs for difficult...

Neuroene Therapeutics

Developing mitochondrial small molecule drugs for difficult to treat neurological diseases.

Founded 2015 United States Washington, United States 4 employees Grant Biotechnology, Health and Wellness

General Information

Company Name Neuroene Therapeutics
Founded Year 2015
Location United States Washington, United States
Employees 4
Industries Biotechnology, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Neuroene Therapeutics. To contact Neuroene Therapeutics, visit neuroenetherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Neuroene Therapeutics

Neuroene Therapeutics is a biotechnology startup based in the United States, founded in 2015. The company's focus lies in developing mitochondrial small molecule drugs for difficult-to-treat neurological diseases. Their innovative approach targets a crucial area of unmet medical need, promising potential breakthroughs in the treatment of neurological disorders. Despite the absence of recent disclosed investments and details regarding investors, the company's dedication to addressing challenging health issues positions them as a compelling prospect for venture capital consideration within the biotech and health and wellness sectors.

No funding data available for Neuroene Therapeutics yet.

Neuroene Therapeutics Alternatives & Competitors

Neuroene Therapeutics vs
Zhimeng Biopharma
Zhimeng Biopharma

Actively advancing innovative small molecule treatments for neurological conditions like epilepsy, p...

Series B
7 employees
Biopharma, Biotechnology
Neuroene Therapeutics vs
Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc. United States

A biotechnology company dedicated to providing small molecule drugs that significantly improve the l...

Grant
272 employees
Biotechnology, Health Care
Neuroene Therapeutics vs
Immunic Therapeutics
Immunic Therapeutics United States

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and...

Post-IPO Equity
91 employees
Biotechnology, Health and Wellness

FAQ About Neuroene Therapeutics

Developing mitochondrial small molecule drugs for difficult to treat neurological diseases.
Neuroene Therapeutics was founded in 2015.
Neuroene Therapeutics is headquartered in Washington, United States.
Neuroene Therapeutics operates in Biotechnology and Health and Wellness.
Neuroene Therapeutics has approximately 4 employees.
Top alternatives and competitors to Neuroene Therapeutics include Zhimeng Biopharma, Rigel Pharmaceuticals Inc., Immunic Therapeutics, Zymeworks Inc., PharmAkea Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neuroene Therapeutics and Zhimeng Biopharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neuroene Therapeutics, https://bouncewatch.com/company/neuroene-therapeutics, updated 23 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes